Jeff Jones | BiotechTV

top of page

Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates

Jeff Jones notes how radioisotopes are being added to more than just antibodies, and calls out upcoming data from Perspective...

Bright Minds

Sep 26, 2024

Houston Oncology Summit: Oppenheimer analyst Jeff Jones on the growth of radiopharmaceuticals

Jeff Jones describes the science behind radiopharmaceuticals and how both new targets and better isotopes are making them more effective.

Bright Minds

Sep 21, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates

Houston Oncology Summit: Oppenheimer analyst Jeff Jones on the growth of radiopharmaceuticals

Follow BiotechTV

Sponsors

Sponsor Spotlight